CHELSEA LYLE: Open Payments
NPI 1861033300 · TUPELO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$326 in 18 payments from 9 companies in 2025. Trend: 2023 $90 · 2024 $339 · 2025 $326
Food & beverage: $326
| Company | Payments | Amount |
|---|---|---|
| MILLICENT US INC | 4 | $66 |
| ABBVIE INC. | 3 | $55 |
| Astellas Pharma US Inc | 2 | $47 |
| Amgen Inc. | 2 | $31 |
| Exeltis, USA Inc. | 2 | $30 |
| Ardelyx, Inc. | 1 | $29 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $29 |
| Hologic Sales and Service, LLC | 1 | $25 |
| Organon LLC | 1 | $15 |
Products named: Veozah, FEMRING, EVENITY, SLYND, INTRAROSA, IBSRELA, ACESSA PROVU SYSTEM, QULIPTA.
Industry payments across MS — which companies pay providers there.
